Loading viewer...
report
Format: PDF report
This report presents primary results from a Phase 1 study of Antolimab, an investigational antibody for treating chronic gastrointestinal symptoms linked to mast cells.
presentation
report
Boston Consulting Group
report
Borqs Technologies
report
Abbott Laboratories
report
The Lottery Corporation